Elevation of Nε-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis

Clinical Biochemistry

Volumn 39, Issue 1, 2006, Pages 39-45

  Yagmur, Eray ^a   Tacke, Frank ^b   Weiss, Claudia ^c   Lahme, Birgit ^a   Manns, Michael P ^b   Kiefer, Paul ^a   Trautwein, Christian ^a,b   Gressner, Axel M ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Advanced glycation end products; Carboxymethyl(lysine); Chronic liver disease; Hyaluronan; Hyaluronic acid; Liver cirrhosis; Serum marker

Indexed keywords

LYSINE DERIVATIVE; ADVANCED GLYCATION END PRODUCT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; HYALURONIC ACID; LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ARTICLE; BLOOD LEVEL; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GLYCATION; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PATIENT; PRIORITY JOURNAL; ADOLESCENT; AGED; BLOOD; CHRONIC DISEASE; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYALURONIC ACID; LIVER CIRRHOSIS; LYSINE; MALE; MIDDLE AGED;

EID: 29344443061     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2005.07.016     Document Type: Article

References (41)

1. H.L. Reeves, and S.L. Friedman Activation of hepatic stellate cells-A key issue in liver fibrosis Front. Biosci. 7 2002 808 826
2. A.M. Gressner, and M.G. Bachem Molecular mechanisms of liver fibrogenesis-A homage to the role of activated fat-storing cells Digestion 56 1995 335 346
3. V. Desmet, and J. Fevery Liver biopsy Bailliere's Clin. Gastroenterol. 9 1995 811 828
4. P. Bedossa, D. Dagere, and V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457
5. D.B. McGill, J. Rakela, A.R. Zinsmeister, and B.J. Ott A 21-year experience with major hemorrhage after percutaneous liver biopsy Gastroenterology 99 1990 1396 1400
6. S. Reddy, J. Bichler, K.J. Wells-Knecht, S.R. Thorpe, and J.W. Baynes Nε(carboxymethyl)lysine is a dominant advanced glycation endproduct (AGE) antigen in tissue proteins Biochemistry 34 1995 10872 10878
7. K. Ikeda, T. Higashi, and H. Sano N-epsilon-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction Biochemistry 35 1996 8075 8083
8. T. Niwa, T. Katsuzaki, and T. Momoi Modification of β2m with advanced glycation end products as observed in dialysis-relate amyloidosis by 3-DG accumulating in uremic serum Kidney Int. 49 1996 861 867
9. T. Hayashi, and M. Namiki M. Fujinaki M. Namiki H. Kato Amino-carbonyl reaction in food and biological systems 1986 Elsevier Amsterdam 29 38
10. K.J. Wells-Knecht, D.V. Zyzak, J.E. Litchfield, S.R. Thorpe, and J.W. Baynes Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucise Biochemistry 34 1995 3702 3709
11. S. Vasan, X. Zhang, and A. Kapumiotu An agent cleaving glucose-derived protein crosslinks in vitro and in vivo Nature 382 1996 275 278
12. H. Makino, K. Shikata, and K. Hironaka Ultrastructure of non-enzymatically glycated mesangial matrix in diabetic nephropathy Kidney Int. 48 1995 517 526
13. K. Yamada, H. Nakano, and M. Nakayama Immunohisto-chemical study of human advanced glycolysation end products (AGE) in chronic renal failure Clin. Nephrol. 42 1994 354 361
14. S. Kume, M. Takeya, and T. Mori Immunohistological and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a noval specific monoclonal antibody Am. J. Pathol. 147 1995 654 667
15. R. Bucala, and A. Cerami Advanced glycolysation: chemistry, biology, and implications diabetes and aging Adv. Pharmacol. 23 1992 1 34
16. H. Fehrenbach, R. Weiskirchen, M. Kasper, and A.M. Gressner Upregulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferenciation to myofibroblasts Hepatology 34 2001 943 952
17. L.G. Bucciarelli, T. Wendt, and L. Rong RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease Cell. Mol. Life Sci. 59 2002 1117 1128
18. T. Kislinger, C. Fu, and B. Huber Nε-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signalling pathways and modulate gene expression J. Biol. Chem. 274 1999 31740 31749
19. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The biology of the receptor for advanced glycation end products and its ligands Biochim. Biophys. Acta 1498 2000 99 111
20. F. Tacke, G. Brabant, and E. Kruck Ghrelin in chronic liver disease J. Hepatol. 38 2003 447 454
21. R.N.H. Pugh, M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, and R. Williams Transection of the oesophagus for bleeding oesophageal varices Br. J. Surg. 60 1973 646 649
22. X. Zhang, M. Frischmann, and R. Kientsch-Engel Two immunochemical assays advanced glycation and-products in serum from dialysis patients Clin. Chem. Lab. Med. 43 2005 503 511
23. M. Lindqvest, K. Chichibu, and B. Delpech Seven different assays of hyaluronan compared for clinical utility Clin. Chem. 38 1992 127 132
24. K. Sebekova, V. Kupcova, R. Schinzel, and A. Heidland Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis-Amelioration by liver transplantation J. Hepatol. 36 2002 66 71
25. B. Smedsrød, J. Melkko, N. Araki, H. Sano, and S. Houriuchi Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells Biochem. J. 322 1997 567 573
26. H. Vlassara Recent progress in advanced glycation end products and diabetic complications Diabetes 46 1997 519 525
27. P.J. Thornalley Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs Mol. Biol. 44 1998 1013 1023
28. S. Eriksson, J.R.E. Fraser, H. Pertoft, and B. Smedsrød Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver Exp. Cell Res. 144 1983 223 228
29. B. Smedsrød, H. Pertoft, S. Eriksson, R.E. Fraser, and T.C. Laurent Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells Biochem. J. 222 1984 617 626
30. J.R.E. Fraser, D. Alcorn, T.C. Laurent, A.D. Robinson, and G.B. Ryan Uptake of circulating hyaluronic acid by rat liver endothelial cells: evidence for receptor recycling Biochem. J. 257 1985 875 884
31. J.G. McHutchison, L.M. Blatt, and M. de Medina Measurement of serum hyaluronate acid in patients with chronic hepatitis C and its relationship to liver histology J. Gastroenterol. Hepatol. 15 2000 945 951
32. A. Nyberg, A. Engstrom-Laurent, and L. Loof Serum hyaluronate in primary biliary cirrhosis: a biochemical marker for progressive liver damage Hepatology 8 1988 142 146
33. T. Ueno, S. Inuzuka, and M. Sata Serum hyaluronate predicts response to interferon alpha therapy in patients with chronic hepatitis C Hepatogastroenterology 42 1995 522 527
34. P.N. Bramley, B.J. Rathbone, M.A. Forbes, E.H. Cooper, and M.S. Losowsky Serum hyaluronate as marker of hepatic derangement in acute liver damage J. Hepatol. 13 1991 8 13
35. T. Körner, J. Kropf, B. Kosche, H. Kristahl, D. Jaspersen, and A.M. Gressner Improvement of prognostic power of the Child-Pugh classification of liver cirrhosis by hyaluronan J. Hepatol. 39 2003 948 954
36. D. Svistounov, and B. Smedsrød Hepatic clearance of advanced glycation end products (AGEs)-Myth or truth J. Hepatol. 41 2004 1038 1040
37. M.A. Glomb, and V.M. Monnier Mechanisms of protein modification by Glyoxal and Glycolaldehyde, reactive intermediates of the Maillard reaction J. Biol. Chem. 17 1995 10017 10026
38. S. Youssef, T. Soulis, and M.E. Cooper Hepatic advanced glycation endproduct binding is increased in experimental diabetes Cell. Mol. Biol. 44 1998 1095 1100
39. M.J. Czaja Induction and regulation of hepatocyte apoptosis by oxidative stress Antioxid. Redox Signal. 4 2002 759 767
40. E. Lasnier, M.C. Blanc, C. Housset, C. Rey, M. Roch Arveiller, and M. Vaubourdolle Cytotoxic response of sinusoidal endothelial cells to polymorphonuclear leukocytes and its potential implication in hypoxia-reoxygenation injury Liver 22 2002 495 500
41. P. Greenwel, J.A. Dominguez-Rosales, G. Mavi, A.M. Rivasestilla, and M. Rojkind Hydrogen peroxide: a link between acetaldehyde-elicited alpha 1(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells Hepatology 31 2000 109 116